Recent advancement on development of drug-induced macrophage polarization in control of human diseases

Life Sci. 2021 Nov 1:284:119914. doi: 10.1016/j.lfs.2021.119914. Epub 2021 Aug 26.

Abstract

Macrophages, an important part of human immune system, possess a high plasticity and heterogeneity (macrophage polarization) as classically activated macrophages (M1) and alternatively activated macrophages (M2), which exert pro-inflammatory/anti-tumor and anti-inflammatory/pro-tumor effects, respectively. Thus, drug development in induction of macrophage polarization could be used to treat different human diseases. This review summarizes the recent advancement on modulation of macrophage polarization and its related molecular mechanisms induced by a number of agents. Research on the anti-inflammatory drugs to regulate the macrophage polarization accounts for a large proportion in the field and types of diseases investigated could include atherosclerosis, enteritis, nephritis, and the nervous system and skeletal diseases, while study of the anti-tumor agents to modify macrophage polarization is a novel area of research. Future study of the molecular mechanisms by which the different agents regulate the macrophage polarization could lead to an effective control of various human diseases, including inflammation and cancers.

Keywords: Drug; M1 macrophage; M2 macrophage; Macrophage polarization; Molecular mechanism.

Publication types

  • Review

MeSH terms

  • Animals
  • Cell Polarity* / genetics
  • Disease*
  • Humans
  • Macrophages / cytology*
  • Macrophages / metabolism
  • Pharmaceutical Preparations / metabolism*
  • Signal Transduction / genetics

Substances

  • Pharmaceutical Preparations